This report describes and summarises the national results of the external quality assessment (EQA) of laboratory performance for those laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2021.
This report provides an analysis of the external quality assessment (EQA) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2017.
An EQA scheme for antimicrobial susceptibility testing of Neisseria gonorrhoeae has been available to laboratories participating in ECDC’s European Sexually Transmitted Infections (STI) surveillance network since 2010. This EQA scheme has so far shown high levels of inter-laboratory comparability in the presence of differing methodologies.
This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.
This report presents the results of the influenza virus antiviral (AV) susceptibility external quality assessment (EQA) which was held for European reference laboratories.
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This report presents the results of the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008.
This report presents the results of the third round of the external quality assessment (EQA) on antimicrobial
susceptibility testing (AST) for national public health laboratories on Salmonella (hereafter Salmonella EQA3-AST).
ECDC is publishing the first external quality assurance scheme (EQA) for Bordetalla pertusis PCR, participated by 21-one laboratories from 21 European Union/European Economic Area countries.
This is the first EQA exercise for laboratories participating in surveillance from the ELDSNet network that has been
organised by ECDC since 2015 and the EQA format and arrangements have changed. The current EQA scheme
uses an outbreak scenario with a package of clinical and environmental samples for the participating laboratories to process, depending on their technical capacity and protocols.